In Vivo Absorption, Metabolism, Excretion (AME) Clinical Study of [14C]Afuresertib in Healthy Chinese Male Adults - Human Mass Balance and Biotransformation Study of [14C]Afuresertib
Latest Information Update: 17 May 2023
At a glance
- Drugs Afuresertib (Primary)
- Indications Breast cancer; HER2 negative breast cancer; Ovarian cancer; Prostate cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Laekna Therapeutics
- 10 May 2023 Status changed from recruiting to completed.
- 12 Sep 2022 Status changed from not yet recruiting to recruiting.
- 11 Aug 2022 New trial record